FDA Inspection
Hikma Pharmaceuticals USA, Inc.Hikma Pharmaceuticals USA, Inc. – FDA Inspection, Feb 26, 2014
Record Details
This FDA Inspection record concerns Hikma Pharmaceuticals USA, Inc., with an inspection on February 26, 2014, issued by the Center for Drug Evaluation and Research, covering drugs.
- Inspection Date
- February 26, 2014
- Product Type
- Drugs
View Company Profile
ID · 43cf47d1-bde3-4a28-8f72-4cfd10f40264
Inspection Facts
Voluntary Action Indicated (VAI)
Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.
- Inspection number
- 864847
- FDA center
- Human Drugs
- Project area
- Drug Quality Assurance
FDA Citations
1- 21 CFR 211.192Extent of discrepancy, failure investigations
Full citation text and observation details available on the Dashboard.
Other FDA inspections of Hikma Pharmaceuticals USA, Inc.
12| Date | Classification | Office | Project area |
|---|---|---|---|
| February 1, 2019 | NAI | Center for Drug Evaluation and Research | Bioresearch Monitoring |
| April 13, 2018 | NAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| July 7, 2016 | NAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| September 10, 2015 | NAI | Center for Drug Evaluation and Research | Bioresearch Monitoring |
| June 7, 2013 | OAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
Other documents for Hikma Pharmaceuticals USA, Inc.
- FDA Inspection 1079961 - 2019-02-01
- FDA Inspection 1054739 - 2018-04-13
- FDA Inspection 976090 - 2016-07-07
- FDA Inspection 942928 - 2015-09-10
- FDA Inspection 829253 - 2013-06-07
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.